A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare Co., Ltd.) today announced that it has contributed to the research, and implementation of the pharmacogenomics (PGx) test ...

So pharmacogenomics is a real opportunity both for the healthcare providers as well as individuals themselves to get a better understanding based on their specific genes on which medications are ...

Aware of this aspect, the pharmaceutical industry has recently started to implement pharmacogenomics into the drug-development pipeline by correlating quantitative measures derived from ...

Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...

Dublin, April 08, 2026 (GLOBE NEWSWIRE)-- The "Pharmacogenomics Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmacogenomics Market is ...

Avera Health, an integrated system in the Midwest, uses pharmacogenomics to allow providers to pick the right medication for a specific patient, and delivers the information to the clinical point of ...

Pharmacogenomics is the field of study about the effect of genes on an individual’s response to medications. It combines the science of drugs, which is known as pharmacology, with the study of genes, ...

Clinical trials offer a slew of benefits: optimal dosage ranges, identified potential side effects, and efficacy data. If approved by the FDA, clinicians leverage the insights from Phase III trials to ...

The list of known variants affecting type 2 diabetes mellitus (T2DM) risk confirms that this disease has a multifactorial aetiology The concept of precision medicine has been exemplified in ...

Coronary disease is one of the most significant causes of death among women in the United States; it is responsible for one in every three deaths. Advancing age, along with other contributing factors, ...

Since the response to psychotropic medication is a complex trait, the identification of key phenotypic measures for its definition is still a major issue in psychiatry. As a consequence, ...